Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of the safety and efficacy of labor induction with oral misoprostol in different doses
IRCT20221123056587N1Phase 4Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of misoprostol in Preterm prelabor rupture of membranes (PPROM) (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Safety of oral misoprostol at different doses and Efficacy of oral misoprostol at different doses. Started Mar 2021; status: completed.
02
Drugs
misoprostol
03
Conditions
Preterm prelabor rupture of membranes (PPROM)
Beyond the preview
Go deeper on IRCT20221123056587N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221123056587N1.